Dr. Hall leads GRAIL’s global Medical Affairs organization, responsible for advancing understanding of the evidence supporting multi-cancer early detection (MCED) and helping healthcare professionals and health systems integrate Galleri responsibly and effectively into clinical practice. Her team works across scientific engagement, medical education, evidence generation and communication, health economics and outcomes research, and real-world evidence to help translate GRAIL’s growing body of clinical data into meaningful clinical practice.

Prior to GRAIL, Dr. Hall was Director of Medical Communications at Jazz Pharmaceuticals, where she led healthcare provider engagement and education strategies for the company’s hematology/oncology and chronic pain portfolios. Previously, she established and built the Medical Communications team at Natera to support the launch and evolution of the Panorama non-invasive prenatal test, and served as an editor at the flagship open-access journal PLOS Biology.

Earlier in her career, Dr. Hall held research positions supported by the American Heart Association, California Institute for Regenerative Medicine, National Institutes of Health, and Howard Hughes Medical Institute. She earned a BS in Biological Sciences from the University of California, Santa Barbara, and a PhD in Microbiology, Immunology, and Molecular Genetics from the University of California, Los Angeles.